Listen: Gilead’s growing pains, Covid’s origins, & Theranos as prestige TV

Dive into the 200th episode of "The Readout LOUD" #podcast: Can biotech companies age gracefully? Where did Covid-19 come from? And does Theranos make for good television? We cover all…

Can biotech companies age gracefully? Where did Covid-19 come from? And does Theranos make for good television?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We examine Gilead Sciences’ recent struggles and what the company’s predicament says about the drug industry. Then, MIT Technology Review reporter Antonio Regalado joins us to discuss his new podcast investigating the origins of Covid-19. We also discuss the latest Theranos trial, playing Elizabeth Holmes on TV, and how we managed to make 200 episodes of this show.

Read the rest…